Proteasome function and pathological proteins in the pathogenesis of Parkinson's disease

J Pharmacol Sci. 2005 Mar;97(3):455-6. doi: 10.1254/jphs.ltj05002x. Epub 2005 Mar 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Disease Models, Animal
  • Dopamine / metabolism
  • Humans
  • Lewy Bodies / drug effects
  • Lewy Bodies / metabolism
  • Lewy Bodies / pathology
  • Mutation
  • Neurotoxins / pharmacology*
  • Oxidopamine / pharmacology*
  • Parkinson Disease / etiology*
  • Parkinson Disease / genetics
  • Parkinson Disease / metabolism
  • Parkinson Disease / pathology
  • Proteasome Endopeptidase Complex / metabolism*
  • Proteasome Inhibitors
  • Protective Agents / metabolism*
  • Rats
  • Substantia Nigra / pathology
  • Ubiquitin-Protein Ligases / genetics

Substances

  • Neurotoxins
  • Proteasome Inhibitors
  • Protective Agents
  • Oxidopamine
  • Ubiquitin-Protein Ligases
  • parkin protein
  • Proteasome Endopeptidase Complex
  • Dopamine